These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1913646

  • 1. Biochemical evidence that glucocorticoid-sensitive cell lines derived from the human leukemic cell line CCRF-CEM express a normal and a mutant glucocorticoid receptor gene.
    Palmer LA, Harmon JM.
    Cancer Res; 1991 Oct 01; 51(19):5224-31. PubMed ID: 1913646
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid receptor expression in receptorless mutants isolated from the human leukemic cell line CEM-C7.
    Harmon JM, Elsasser MS, Eisen LP, Urda LA, Ashraf J, Thompson EB.
    Mol Endocrinol; 1989 Apr 01; 3(4):734-43. PubMed ID: 2725534
    [Abstract] [Full Text] [Related]

  • 3. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.
    Powers JH, Hillmann AG, Tang DC, Harmon JM.
    Cancer Res; 1993 Sep 01; 53(17):4059-65. PubMed ID: 8358735
    [Abstract] [Full Text] [Related]

  • 4. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.
    Ashraf J, Thompson EB.
    Mol Endocrinol; 1993 May 01; 7(5):631-42. PubMed ID: 8316249
    [Abstract] [Full Text] [Related]

  • 5. [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor.
    Schlechte JA, Simons SS, Lewis DA, Thompson EB.
    Endocrinology; 1985 Oct 01; 117(4):1355-62. PubMed ID: 4029081
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
    Hala M, Hartmann BL, Böck G, Geley S, Kofler R.
    Int J Cancer; 1996 Nov 27; 68(5):663-8. PubMed ID: 8938150
    [Abstract] [Full Text] [Related]

  • 7. Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens.
    Palmer LA, Hukku B, Harmon JM.
    Cancer Res; 1992 Dec 01; 52(23):6612-8. PubMed ID: 1384968
    [Abstract] [Full Text] [Related]

  • 8. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
    Schmidt TJ.
    Cancer Res; 1989 Aug 15; 49(16):4390-5. PubMed ID: 2743328
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor.
    Zawydiwski R, Harmon JM, Thompson EB.
    Cancer Res; 1983 Aug 15; 43(8):3865-73. PubMed ID: 6134583
    [Abstract] [Full Text] [Related]

  • 10. Molybdate-sensitive and molybdate-resistant activation-labile glucocorticoid-receptor mutants of the human lymphoid cell line CEM-C7.
    Harmon JM, Schmidt TJ, Thompson EB.
    J Steroid Biochem; 1984 Sep 15; 21(3):227-36. PubMed ID: 6492789
    [Abstract] [Full Text] [Related]

  • 11. Differential autoregulation of glucocorticoid receptor expression in human T- and B-cell lines.
    Denton RR, Eisen LP, Elsasser MS, Harmon JM.
    Endocrinology; 1993 Jul 15; 133(1):248-56. PubMed ID: 8319574
    [Abstract] [Full Text] [Related]

  • 12. Use of [3H]cortivazol to characterize glucocorticoid receptors in a dexamethasone-resistant human leukemic cell line.
    Schlechte JA, Schmidt TJ.
    J Clin Endocrinol Metab; 1987 Mar 15; 64(3):441-6. PubMed ID: 2880860
    [Abstract] [Full Text] [Related]

  • 13. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines.
    Pedersen KB, Vedeckis WV.
    Biochemistry; 2003 Sep 23; 42(37):10978-90. PubMed ID: 12974633
    [Abstract] [Full Text] [Related]

  • 14. Complementation between glucocorticoid receptor and lymphocytolysis in somatic cell hybrids of two glucocorticoid-resistant human leukemic clonal cell lines.
    Yuh YS, Thompson EB.
    Somat Cell Mol Genet; 1987 Jan 23; 13(1):33-45. PubMed ID: 3468632
    [Abstract] [Full Text] [Related]

  • 15. The antiglucocorticoid, cortexolone, fails to promote in vitro activation of cytoplasmic glucocorticoid receptors from the human leukemic cell line CEM-C7.
    Schmidt TJ, Davidson CJ.
    J Steroid Biochem; 1987 Mar 23; 26(3):329-36. PubMed ID: 3586649
    [Abstract] [Full Text] [Related]

  • 16. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R.
    Cancer Res; 1996 Nov 01; 56(21):5033-8. PubMed ID: 8895760
    [Abstract] [Full Text] [Related]

  • 17. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
    Schmidt TJ.
    J Steroid Biochem; 1986 Apr 01; 24(4):853-63. PubMed ID: 2871233
    [Abstract] [Full Text] [Related]

  • 18. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies.
    Lee S, Duncan KA, Chou H, Chen D, Kohli K, Huang CF, Stallcup MR.
    Mol Endocrinol; 1995 Jul 01; 9(7):826-37. PubMed ID: 7476966
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells.
    Ramdas J, Harmon JM.
    Endocrinology; 1998 Sep 01; 139(9):3813-21. PubMed ID: 9724034
    [Abstract] [Full Text] [Related]

  • 20. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line.
    Strasser-Wozak EM, Hattmannstorfer R, Hála M, Hartmann BL, Fiegl M, Geley S, Kofler R.
    Cancer Res; 1995 Jan 15; 55(2):348-53. PubMed ID: 7812967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.